Reaction
Smear Cervix Abnormal reporting signals
As of the last recalculation, Smear Cervix Abnormal appears in 1,412 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is ETONOGESTREL AND ETHINYL ESTRADIOL (PRR 66.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Etonogestrel And Ethinyl Estradiol | 94 | 66.9 | 67.1 |
| Anakinra | 56 | 51.8 | 51.9 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 49 | 35.0 | 35.1 |
| Copper | 88 | 32.0 | 32.1 |
| Levonorgestrel | 226 | 19.5 | 19.5 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 24 | 15.2 | 15.2 |
| Sulfasalazine | 56 | 10.9 | 11.0 |
| Medroxyprogesterone Acetate | 34 | 10.3 | 10.3 |
| Leflunomide | 65 | 9.5 | 9.6 |
| Naproxen Sodium Tablet, Coated | 8 | 8.8 | 8.8 |
| Naproxen Sodium, Coated Tablets | 8 | 8.8 | 8.8 |
| Naproxen Sodium 220Mg | 8 | 8.7 | 8.7 |
| Estrogens, Conjugated | 34 | 8.6 | 8.6 |
| Conjugated Estrogens | 33 | 8.5 | 8.5 |
| Cladribine | 5 | 7.7 | 7.7 |
| Ocrelizumab | 31 | 7.5 | 7.5 |
| Fingolimod Hcl | 36 | 6.3 | 6.3 |
| Etonogestrel | 14 | 4.4 | 4.4 |
| Drospirenone And Ethinyl Estradiol | 11 | 3.7 | 3.7 |
| Natalizumab | 42 | 3.5 | 3.5 |